A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet

A Randomized, Open-label, Single Dose, Two-way Crossover Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet in Healthy Female Volunteers

The purpose of this study is to evaluate the Pharmacokinetics and Safety / Tolerability of BR-UPS (Ulipristal acetate) 5 mg tablet with Inisia (Ulipristal acetate) 5 mg tablet in healthy female volunteers

This is a randomized, open-label, single dose, two-way crossover study to compare the pharmacokinetics and safety/tolerability of BR-UPS (Ulipristal acetate) 5 mg tablet with Inisia (Ulipristal acetate) 5 mg tablet in healthy female volunteers

Inclusion Criteria:

• A subject provide written informed consent which he voluntarily confirms willingness to participate in a study, having been informed of the full details of the study and comply with the protocol.
• A Healthy female volunteers, aged 19-45 years
• BMI 18 ~ 27(kg/m2)

Exclusion Criteria:

• History or presence of clinically significant medical or psychiatric condition or disease.
• History of gastrointestinal disease and resection
• History of clinically significant hypersensitivity to study drug, any other drug
• A subject with clinically significant genital bleeding
• Participation in any other study within 3 months
• Positive results for urine β-hCG in screening or lactating women
• A subject is using a method of hormone contraception and a Progesterone intrauterine device